Published in J Infect Dis on June 01, 1996
The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol (2001) 5.70
Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun (2000) 3.59
PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol (1996) 3.54
Enteric infections, diarrhea, and their impact on function and development. J Clin Invest (2008) 3.23
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun (2000) 2.10
Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J Bacteriol (1996) 1.92
PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp. Infect Immun (1999) 1.85
Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun (2007) 1.83
Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death. Proc Natl Acad Sci U S A (2001) 1.73
Salmonella enterica serovar typhimurium invasion is repressed in the presence of bile. Infect Immun (2000) 1.63
Immunology of gut mucosal vaccines. Immunol Rev (2011) 1.59
A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe (2010) 1.46
Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun (2000) 1.44
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun (1997) 1.43
Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A (2010) 1.41
Comparative analysis of Salmonella enterica serovar Typhimurium biofilm formation on gallstones and on glass. Infect Immun (2003) 1.37
Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect Immun (2002) 1.33
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect Immun (2000) 1.32
Bacterial infectious disease control by vaccine development. J Clin Invest (2002) 1.30
Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun (2001) 1.27
Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol (2007) 1.23
Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol Cell Biol (2009) 1.21
CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun (2005) 1.20
Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant. Infect Immun (1998) 1.20
Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother (2014) 1.19
Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun (2004) 1.17
Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. Curr Opin Microbiol (2014) 1.16
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 1.15
Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. Infect Immun (1999) 1.13
Genomic subtraction identifies Salmonella typhimurium prophages, F-related plasmid sequences, and a novel fimbrial operon, stf, which are absent in Salmonella typhi. J Bacteriol (1999) 1.13
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunol (2008) 1.10
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi. Infect Immun (2011) 1.05
Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun (2006) 1.03
Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun (2006) 1.02
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915. Infect Immun (2001) 1.01
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Infect Immun (2000) 0.99
Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1. J Virol (2004) 0.99
Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward. Front Immunol (2014) 0.99
Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity. Infect Immun (2004) 0.98
Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS One (2009) 0.98
Constitutive mutations of the Salmonella enterica serovar Typhimurium transcriptional virulence regulator phoP. Infect Immun (2000) 0.96
The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun (1999) 0.95
Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect Immun (2010) 0.94
The delicate balance in genetically engineering live vaccines. Vaccine (2013) 0.92
Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers. Infect Immun (1997) 0.90
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria. Antibiotics (Basel) (2015) 0.90
Attenuated Listeria monocytogenes vaccine vectors expressing influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers. Microbiol Immunol (2011) 0.87
Live attenuated vaccines for invasive Salmonella infections. Vaccine (2015) 0.86
Typhoid fever & vaccine development: a partially answered question. Indian J Med Res (2012) 0.85
Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo. Cancer Lett (2013) 0.84
Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci. Infect Immun (2004) 0.82
Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect Immun (1999) 0.81
Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi. J Infect Dev Ctries (2008) 0.80
Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag. Viruses (2013) 0.80
A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity. Cancer Biol Ther (2014) 0.80
Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems. Infect Immun (2000) 0.80
Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC. Cancer Gene Ther (2012) 0.80
Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment. J Cancer Res Clin Oncol (2013) 0.79
Low-pH rescue of acid-sensitive Salmonella enterica Serovar Typhi Strains by a Rhamnose-regulated arginine decarboxylase system. J Bacteriol (2013) 0.79
Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection. Infect Immun (2014) 0.78
Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks. Yale J Biol Med (2010) 0.78
Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens. Expert Rev Vaccines (2011) 0.78
Attenuating gene expression (AGE) for vaccine development. Virulence (2013) 0.78
Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method. Microb Pathog (2016) 0.77
Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid. PLoS One (2015) 0.77
Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination. Clin Vaccine Immunol (2007) 0.77
Identification of the Avian Pasteurella multocida phoP Gene and Evaluation of the Effects of phoP Deletion on Virulence and Immunogenicity. Int J Mol Sci (2015) 0.76
Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth. Asian J Androl (2012) 0.76
Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity. Ecosal Plus (2016) 0.75
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Drug Des Devel Ther (2016) 0.75
Acidic pH sensing in the bacterial cytoplasm is required for Salmonella virulence. Mol Microbiol (2016) 0.75
Animal Models for Salmonellosis: Applications in Vaccine Research. Clin Vaccine Immunol (2016) 0.75
phoP, SPI1, SPI2 and aroA mutants of Salmonella Enteritidis induce a different immune response in chickens. Vet Res (2015) 0.75
Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer. Sci Rep (2017) 0.75
Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med (1993) 6.88
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science (1997) 4.81
Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci U S A (1992) 4.72
Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol (1993) 4.62
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science (1999) 3.98
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97
A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J Bacteriol (1993) 3.91
Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun (2000) 3.59
PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol (1996) 3.54
A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proc Natl Acad Sci U S A (2000) 3.39
Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol Microbiol (1999) 3.15
PhoP/PhoQ transcriptional repression of Salmonella typhimurium invasion genes: evidence for a role in protein secretion. Mol Microbiol (1995) 3.11
Contribution of Salmonella typhimurium type III secretion components to needle complex formation. Proc Natl Acad Sci U S A (2000) 3.10
Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol (1992) 3.03
Salmonella: a model for bacterial pathogenesis. Annu Rev Med (2001) 2.99
Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes. J Exp Med (1994) 2.85
A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J Bacteriol (1991) 2.82
Salmonella typhimurium secreted invasion determinants are homologous to Shigella Ipa proteins. Mol Microbiol (1995) 2.65
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53
Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response-regulator superfamily. Mol Microbiol (1996) 2.46
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect Immun (1995) 2.35
Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect Immun (1999) 2.35
Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence. Nucleic Acids Res (1986) 2.33
A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem (2000) 2.32
Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem (2001) 2.30
A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol (2000) 2.26
Development of a live, oral, attenuated vaccine against El Tor cholera. J Infect Dis (1994) 2.06
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis (1995) 2.05
Predicting readmission to the psychiatric hospital in a managed care environment: implications for quality indicators. Am J Psychiatry (1997) 2.02
Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J Bacteriol (1996) 1.92
Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect (2001) 1.91
Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci. Infect Immun (1994) 1.80
A HilA-independent pathway to Salmonella typhimurium invasion gene transcription. J Bacteriol (1999) 1.76
How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis (1999) 1.68
Characterization of the Salmonella typhimurium pagC/pagD chromosomal region. J Bacteriol (1995) 1.63
SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J Bacteriol (2001) 1.58
Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J (2001) 1.51
Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine (1996) 1.46
Purification and primary structure of murine cryptdin-1, a Paneth cell defensin. FEBS Lett (1992) 1.42
Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine (1999) 1.41
Heterologous antigen expression in Vibrio cholerae vector strains. Infect Immun (1995) 1.41
Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc Natl Acad Sci U S A (1995) 1.38
Bacteriophages in the evolution of pathogen-host interactions. Proc Natl Acad Sci U S A (1999) 1.37
Identification of PhoP-PhoQ activated genes within a duplicated region of the Salmonella typhimurium chromosome. Microb Pathog (1998) 1.35
Salmonella enterica serovar typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence In vivo. Infect Immun (2000) 1.32
Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect Immun (1995) 1.32
Hypoglycemia as a manifestation of sepsis. Am J Med (1980) 1.26
The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection. Mol Microbiol (2000) 1.24
InvB is a type III secretion chaperone specific for SspA. J Bacteriol (2000) 1.24
Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect Immun (1996) 1.21
An unusual pagC::TnphoA mutation leads to an invasion- and virulence-defective phenotype in Salmonellae. Infect Immun (1992) 1.15
Genomic subtraction identifies Salmonella typhimurium prophages, F-related plasmid sequences, and a novel fimbrial operon, stf, which are absent in Salmonella typhi. J Bacteriol (1999) 1.13
Alcohol abuse during pregnancy: an epidemiologic study. Alcohol Clin Exp Res (1980) 1.11
SspA is required for lethal Salmonella enterica serovar Typhimurium infections in calves but is not essential for diarrhea. Infect Immun (2000) 1.06
Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun (2000) 1.02
Chromosome location of four genes in Leishmania. Mol Biochem Parasitol (1986) 1.02
Transcriptional mapping of Leishmania enrietti tubulin mRNAs. Mol Biochem Parasitol (1986) 0.99
Zinc status of pregnant alcoholic women: a determinant of fetal outcome. Lancet (1981) 0.99
Significant determinants of susceptibility to alcohol teratogenicity. Ann N Y Acad Sci (1986) 0.98
Heat shock proteins of vegetative and fruiting Myxococcus xanthus cells. J Bacteriol (1986) 0.97
Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. Eur J Immunol (2001) 0.97
Constitutive mutations of the Salmonella enterica serovar Typhimurium transcriptional virulence regulator phoP. Infect Immun (2000) 0.96
Salmonella typhimurium recognition of intestinal environments. Trends Microbiol (1999) 0.93
A study of psychiatric emergencies. II. Suicide. Psychiatry Med (1970) 0.91
Cell-contact-stimulated formation of filamentous appendages by Salmonella typhimurium does not depend on the type III secretion system encoded by Salmonella pathogenicity island 1. Infect Immun (1998) 0.89
The Cleveland NIAAA prospective alcohol-in-pregnancy study: the first year. Neurobehav Toxicol Teratol (1981) 0.88
A rapid and gentle method for isolation of genomic DNA from pathogenic Nocardia spp. Clin Diagn Lab Immunol (1996) 0.88
Synthesis of and evaluation of lipid A modification by 4-substituted 4-deoxy arabinose analogs as potential inhibitors of bacterial polymyxin resistance. Bioorg Med Chem Lett (2007) 0.88
The treatment of dangerous patients in managed care. Psychiatric hospital utilization and outcome. Gen Hosp Psychiatry (1997) 0.86
Use of commercially available rapid chloramphenicol acetyltransferase test to detect resistance in Salmonella species. J Clin Microbiol (1990) 0.83
A multidimensional problem-oriented review and evaluation system. Am J Psychiatry (1975) 0.83
An evening mental health clinic. Hosp Community Psychiatry (1973) 0.82
Pathologic quiz case 1: cemento-ossifying fibroma of the ethmoidal sinus. Arch Otolaryngol (1979) 0.81
Psychiatric hospital outcomes of dual diagnosis patients under managed care. Am J Addict (1998) 0.80
Characteristics of short-stay admissions to a psychiatric inpatient service. J Behav Health Serv Res (1998) 0.80
Factors predicting patients' satisfaction with managed mental health care. Psychiatr Serv (1995) 0.80
Suicide attempt patterns among the Navajo indians. Int J Soc Psychiatry (1971) 0.79
Photooxidation of phenol, cresols, and dihydroxybenzenes. J Am Chem Soc (1966) 0.79
HIV-1 antibody reactivity in inner-city alcoholics. JAMA (1989) 0.78
Three approaches to the treatment of drug addiction. Hosp Community Psychiatry (1986) 0.78
Elevated superoxide dismutase in black alcoholics. Science (1980) 0.78
Adult children of alcoholics. Hosp Community Psychiatry (1986) 0.77
Serotonin reuptake inhibitors and the adequacy of antidepressant treatment. Int J Psychiatry Med (1997) 0.77
New insights on molecular pathways utilized by salmonella species in cell binding. Front Biosci (1996) 0.77
Interaction of alcohol and zinc in fetal dysmorphogenesis. Pharmacol Biochem Behav (1983) 0.77
Medical-behavioral treatment of the older alcoholic patient. Am J Drug Alcohol Abuse (1984) 0.76
A framework for relating alcoholism and depression. J Fam Pract (1982) 0.76
A study of psychiatric emergencies. 3. Findings on followup. Psychiatry Med (1971) 0.75
Laparoscopic applications in adult and pediatric urology. J S C Med Assoc (1993) 0.75
A multidimensional problem-oriented review and evaluation system for psychiatric patient care. Med Rec News (1977) 0.75
Disulfiram: an unusual side effect. JAMA (1977) 0.75
Logic as a tool for clinical training in social work. Psychiatr Q (1977) 0.75